Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls.
about
Comprehensive quantitative analysis of ovarian and breast cancer tumor peptidomes.Serum biomarkers reflecting specific tumor tissue remodeling processes are valuable diagnostic tools for lung cancer.Highly aligned stromal collagen is a negative prognostic factor following pancreatic ductal adenocarcinoma resection.Protein degradation fragments as diagnostic and prognostic biomarkers of connective tissue diseases: understanding the extracellular matrix message and implication for current and future serological biomarkers.Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients.Excessive matrix metalloprotease-mediated degradation of interstitial tissue (type I collagen) independently predicts short-term survival in an observational study of postmenopausal women diagnosed with cancer.Novel biomarkers and endoscopic techniques for diagnosing pancreaticobiliary malignancyUnique insight into microenvironmental changes in colorectal cancer: Ex vivo assessment of matrix metalloprotease-mediated molecular changes in human colorectal tumor tissue and corresponding non-neoplastic adjacent tissue.Quantification of altered tissue turnover in a liquid biopsy: a proposed precision medicine tool to assess chronic inflammation and desmoplasia associated with a pro-cancerous niche and response to immuno-therapeutic anti-tumor modalities.Age-related collagen turnover of the interstitial matrix and basement membrane: Implications of age- and sex-dependent remodeling of the extracellular matrix.
P2860
Q34855337-ACB7D2E7-02E3-4019-BC65-29F3832BA90BQ34998455-6FECEBE7-D554-46F1-B971-E15FC50534A2Q37689086-46D276C8-A34F-4770-B8CF-547BB4B66F9AQ38675211-544F5072-EDD3-41CD-B836-AA5BB5C1B169Q39553253-E8123952-E42D-4A81-9E08-976C874BAB99Q41592769-AA2F093D-B643-48E9-9C5F-D0F9FCA630BBQ41624551-52212177-4E55-462C-A151-1F3107CB8442Q42143202-42809455-392B-43A5-9DB1-6BCA3099E134Q48206682-EBB11C76-FA45-4FCD-9179-7DCE4A0A6324Q52806365-695E37D8-04DE-4004-9AD6-D2CE41A1785D
P2860
Extracellular matrix specific protein fingerprints measured in serum can separate pancreatic cancer patients from healthy controls.
description
2013 nî lūn-bûn
@nan
2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Extracellular matrix specific ...... atients from healthy controls.
@ast
Extracellular matrix specific ...... atients from healthy controls.
@en
Extracellular matrix specific ...... atients from healthy controls.
@nl
type
label
Extracellular matrix specific ...... atients from healthy controls.
@ast
Extracellular matrix specific ...... atients from healthy controls.
@en
Extracellular matrix specific ...... atients from healthy controls.
@nl
prefLabel
Extracellular matrix specific ...... atients from healthy controls.
@ast
Extracellular matrix specific ...... atients from healthy controls.
@en
Extracellular matrix specific ...... atients from healthy controls.
@nl
P2093
P2860
P356
P1433
P1476
Extracellular matrix specific ...... atients from healthy controls.
@en
P2093
Anne-Christine Bay-Jensen
Cecilie L Bager
David Dornan
Diana J Leeming
Morten A Karsdal
Victoria Smith
P2860
P2888
P356
10.1186/1471-2407-13-554
P407
P577
2013-11-21T00:00:00Z
P5875
P6179
1007663330